Search
  • Martyn Dixon

DyeVert Plus.

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI) Amersham, UK, Minnesota, USA, and Melbourne, Australia — 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).

0 views

Recent Posts

See All

CSI: What's new in Imaging 2/7/20

https://us02web.zoom.us/rec/play/usJ8d-38qzg3TIaX4wSDAv59W9S1LK6shCIX-PIOy0_hUHcHY1CvZLcXYrSv4tmADvTzRn7F62ajLpJF?continueMode=true&_x_zm_rtaid=pLhuv_9cSmutJKfNxyVS-A.1595436956172.86712203383e83ba09a

© 2020 by Cardiologic Ltd